Health A-Z News, Features & Updates

September 30, 2026 — The FDA has approved Gazyva (obinutuzumab) to reduce the risk of disease relapse in adults and children aged 2 years or older with frequently relapsing or steroid-dependent childhood-onset idiopathic nephrotic syndrome who are in complete remission.

August 19, 2026 — The FDA has approved Pasatru (garetosmab-grts) to reduce new abnormal bone growth outside the skeleton and reduce disease flare-ups in adults with fibrodysplasia ossificans progressiva (FOP).

One woman shares what it’s like to live with a rare kidney condition. Read about her diagnosis, treatment, and how life has changed.

Get expert answers about IgA nephropathy symptoms, treatment, monitoring, lifestyle changes, and what to expect over time.

One woman shares her story about life with IgA nephropathy. Read about her diagnosis, treatment, and future goals with this rare kidney condition.

See how IgA nephropathy treatment is changing, from targeted immune therapies to new ways doctors may personalize care.

Peptides are trending, but should you try them? Get the facts on how they work, safety concerns, gray market risks, and how to use them responsibly.

HBO Max's "The Pitt" examines what doctors and patients need to make an overwhelmed health care system work in spite of bureaucracy.

A young professional with immune thrombocytopenia shares how she’s struck a work-life balance, managed fatigue and depression, and explained ITP to others.

An expert offers advice on how to live well with immune thrombocytopenia (ITP). Get tips on how to take charge of symptoms and manage or prevent treatment side effects.

What’s it like to live with hemophilia B? A mom who lives with and has kids also diagnosed with this rare disorder explains.

A hematologist who treats adults with ITP offers a look at advances in treatment and possible future medicines in the pipeline

Hemophilia B can create lifelong physical and emotional challenges. Here’s advice for managing this rare bleeding disorder from a doctor who treats it.

In recent years, researchers have made huge advances in treating hemophilia B. Here’s a look at the latest progress.

November 4, 2025 — The FDA has approved Kygevvi (doxecitine and doxribtimine) as the first oral treatment for thymidine kinase 2 deficiency (TK2d).

A kidney disease expert shares clinical insight on IC-MPGN, including symptoms, treatment, and what to expect and ask as you navigate your care.

Learn about the newest medical research and treatments for IC-MPGN.

IC-MPGN is a rare kidney disease, but a new treatment, pegcetacoplan, can help manage symptoms. One patient advocate shares a glimpse of her life.

Complement 3 glomerulopathy (C3G) is a rare kidney disease that often leads to kidney transplant. See how one woman living with C3G found hope.

Complement 3 glomerulopathy (C3G) is a rare kidney disease that often leads to kidney transplant. Get the latest answers from a C3G expert.

Complement 3 glomerulopathy (C3G) is a rare kidney disease that often leads to kidney transplant. Find hope in the latest C3G treatments and research.

October 8, 2025 — Jascayd (nerandomilast) is a new oral medicine approved to treat idiopathic pulmonary fibrosis, a disease that causes scarring (fibrosis) in the lungs that worsens over time.

October 1, 2025 — Less than 1% of people infected in the U.S. get tested and treated for kissing bug disease (Chagas disease), potentially raising the risk for serious complications like heart failure.

September 26, 2025 — Palsonify (paltusotine) is a new once-daily oral medicine approved to treat adults with acromegaly who either didn’t get much help from surgery or cannot have surgery for certain reasons.

September 24, 2025 — Researchers are linking flight-related exposures – like low cabin pressure, cosmic radiation, and trace chemicals in cabin air – to cancer, blood clots, and neurological symptoms in flight crews. Some warn frequent flyers could be at risk too.

September 12, 2025 — From hemorrhoids to herpes to memory loss and even relationship problems, why do researchers keep discovering new, and surprisingly strange, ways our phones may be harming us?

August 1, 2025 — New research finds that electric fans may help cool you down even in 100 F heat — especially when combined with skin wetting and proper hydration — but become ineffective or harmful at higher temperatures.

Pegcetacoplan is a new treatment for C3G and IC-MPGN. Learn how it works and why it’s a breakthrough for these conditions.

July 15, 2025 — A young mom's painful tale of "medical gaslighting" reveals how the health care system is failing women – and what some are starting to do about it.

June 5, 2025 — Experts explain the risks and benefits of using programs like ChatGPT to analyze results before your doctor calls to discuss them.

April 3, 2025 — The FDA has approved Vanrafia (atrasentan), a once-daily pill that reduces proteinuria in adults with immunoglobulin A nephropathy (IgAN), offering new hope for slowing kidney damage.

March 31, 2025 — The FDA has approved fitusiran (Qfitlia), a first-of-its-kind injectable drug to reduce bleeding episodes in people with certain types of hemophilia.

February 19, 2025 — A new report anticipates a hospital bed shortage as soon as 2032. Here’s how that could impact you.

February 6, 2025 — If you're looking for calm in a toxic world, read advice from scientists who study environmental stress.

Living with chronic kidney disease can be hard. Here's your guide to taking care of your mental health and knowing when and how to get professional help during dialysis.

People with CKD who are on dialysis need a lot of support. Here’s why it’s so important, and resources to help you find it.

Exercise is very important if you have CKD. But it can be hard to do if you’re on dialysis. Learn the benefits and how to fit it into your life.

January 16, 2025 — The breakthrough discovery of a powerful new gene editing tool called bridge RNAs has the potential to significantly advance gene therapy and usher in a new frontier in genome design, researchers say.

December 9, 2024 — Health concerns have prompted the Environmental Protection Agency to ban certain chemicals used for dry cleaning and for making everyday products like glue.

November 14, 2024 — Present-elect Donald Trump has nominated Robert F. Kennedy Jr. to be the country’s next secretary of the Department of Health and Human Services.

November 11, 2024 — This fall, the CDC launched a new program to help reduce diagnostic errors, a leading cause of death in the U.S. Learn how to reduce the chances that a misdiagnosis will happen to you.

November 5, 2024 — Exposure to chemicals called PFAS during young adulthood has been linked to yet another serious health problem – reduced kidney function and kidney disease.

What to know about whole-body scans for body composition and health.

October 30, 2024 — Recent research suggests that standing won’t save you from the health harms of sitting. But before you ditch your standing desk (or your job), consider this expert advice.

October 22, 2024 — Cancer, heart disease, diabetes, Alzheimer’s – the list of diseases linked to nighttime light exposure is getting longer. Here’s what scientists think is happening and what to do about it.

October 14, 2024 — The FDA has approved a new preventive treatment for people with certain types of hemophilia that can reduce bleeding episodes, sometimes down to just a few per year.

October 10, 2024 — Hurricane Helene damaged the nation’s main plant that makes intravenous fluids nearly 2 weeks ago. Here's what to know.

September 25, 2024 — Nearly one-third of U.S. adults may have low iron levels that can add to problems ranging from fatigue to heart failure.

September 9, 2024 — A common food dye turned mice see-through, a "stunning" finding that could revolutionize imaging techniques in medicine.